{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T11:08:05Z","timestamp":1794049685506,"version":"4.8.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T00:00:00Z","timestamp":1180656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2007,6]]},"DOI":"10.1016\/j.neuropharm.2007.03.013","type":"journal-article","created":{"date-parts":[[2007,4,5]],"date-time":"2007-04-05T11:11:57Z","timestamp":1175771517000},"page":"1671-1677","source":"Crossref","is-referenced-by-count":76,"title":["Role of Gq protein in behavioral effects of the hallucinogenic drug 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane"],"prefix":"10.1016","volume":"52","author":[{"given":"Efrain E.","family":"Garcia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randy L.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine","family":"Sanders-Bush","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2007.03.013_bib1","doi-asserted-by":"crossref","first-page":"16S","DOI":"10.1038\/sj.npp.1395318","article-title":"Serotonin and hallucinogens","volume":"21","author":"Aghajanian","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2007.03.013_bib2","first-page":"327","article-title":"Drugs as the\u00a0discriminative events in humans","volume":"2","author":"Altman","year":"1976","journal-title":"Psychopharmacol. Commun."},{"key":"10.1016\/j.neuropharm.2007.03.013_bib3","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0028-3908(99)00010-6","article-title":"A review of central 5-HT receptors and their function","volume":"38","author":"Barnes","year":"1999","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2007.03.013_bib4","first-page":"1814","article-title":"Classification of drugs according to their discriminable effects in rats","volume":"33","author":"Barry","year":"1974","journal-title":"Fed. Proc."},{"key":"10.1016\/j.neuropharm.2007.03.013_bib5","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1124\/mol.54.1.94","article-title":"Effector pathway-dependent relative efficacy at serotonin type 2A and 2C receptors: evidence for agonist-directed trafficking of receptor stimulus","volume":"54","author":"Berg","year":"1998","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2007.03.013_bib6","doi-asserted-by":"crossref","first-page":"7021","DOI":"10.1074\/jbc.275.10.7021","article-title":"Dissecting G protein-coupled receptor signaling pathways with membrane-permeable blocking peptides. Endogenous 5-HT(2C) receptors in choroid plexus epithelial cells","volume":"275","author":"Chang","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2007.03.013_bib7","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/0091-3057(90)90098-3","article-title":"Do functional relationships exist between 5-HT1A and 5-HT2 receptors?","volume":"36","author":"Darmani","year":"1990","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2007.03.013_bib8","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/BF02431535","article-title":"Time course of ethanol's effects on locomotor activity, exploration and anxiety in mice","volume":"96","author":"Durcan","year":"1988","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.neuropharm.2007.03.013_bib9","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/s002130050125","article-title":"Similarities in the pharmacology of spontaneous and DOI-induced head-shakes suggest 5HT2A receptors are active under physiological conditions","volume":"128","author":"Dursun","year":"1996","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.neuropharm.2007.03.013_bib10","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1146\/annurev.pa.36.040196.002405","article-title":"Regulation of phosphoinositide phospholipases by hormones, neurotransmitters, and other agonists linked to G proteins","volume":"36","author":"Exton","year":"1996","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.neuropharm.2007.03.013_bib11","series-title":"The Mouse Brain in Sterotaxic Coordinates","author":"Franklin","year":"1997"},{"key":"10.1016\/j.neuropharm.2007.03.013_bib12","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1016\/0024-3205(84)90436-3","article-title":"Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents","volume":"35","author":"Glennon","year":"1984","journal-title":"Life Sci."},{"key":"10.1016\/j.neuropharm.2007.03.013_bib13","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.neuron.2007.01.008","article-title":"Hallucinogens recruit specific cortical 5-HT2A receptor-mediated signaling pathways to affect behavior","volume":"53","author":"Gonzalez-Maseo","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2007.03.013_bib14","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0166-4328(93)90097-A","article-title":"Role of the amygdala and periaqueductal gray in anxiety and panic","volume":"58","author":"Graeff","year":"1993","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2007.03.013_bib15","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S0306-4522(02)00349-4","article-title":"Lysergic acid diethylamide-induced Fos expression in rat brain: role of serotonin-2A receptors","volume":"114","author":"Gresch","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2007.03.013_bib16","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1007\/s00213-006-0457-5","article-title":"Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance","volume":"187","author":"Griffiths","year":"2006","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.neuropharm.2007.03.013_bib17","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1073\/pnas.95.2.735","article-title":"5-Hydroxytryptamine2A serotonin receptors in the primate cerebral cortex: possible site of action of hallucinogenic and antipsychotic drugs in pyramidal cell apical dendrites","volume":"95","author":"Jakab","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuropharm.2007.03.013_bib18","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0022-3565(24)36843-0","article-title":"Pharmacological characterization of in vivo properties of putative mixed 5-HT1A agonist\/5-HT(2A\/2C) antagonist anxiolytics. II. Drug discrimination and behavioral observation studies in rats","volume":"282","author":"Kleven","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2007.03.013_bib19","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1046\/j.1471-4159.2003.01921.x","article-title":"A\u00a0complex signaling cascade links the serotonin2A receptor to phospholipase A2 activation: the involvement of MAP kinases","volume":"86","author":"Kurrasch-Orbaugh","year":"2003","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2007.03.013_bib20","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/00001756-199312000-00014","article-title":"Lithium enhances 5-HT2A receptor-mediated c-fos expression in rat cerebral cortex","volume":"5","author":"Leslie","year":"1993","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuropharm.2007.03.013_bib21","first-page":"73","article-title":"Inhibition of arachidonic acid cascade attenuates the induction of c-Fos proteins by DOI, 5-HT2A\/2C receptor agonist, in the rat cortex","volume":"54","author":"Mackowiak","year":"2002","journal-title":"Pol. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2007.03.013_bib22","first-page":"1373","article-title":"LSD and the phenethylamine hallucinogen DOI are potent partial agonists at 5-HT2A receptors on interneurons in rat piriform cortex","volume":"278","author":"Marek","year":"1996","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2007.03.013_bib23","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/BF02245187","article-title":"Evidence that 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI)-induced hyperthermia in rats is mediated by stimulation of 5-HT2A receptors","volume":"117","author":"Mazzola-Pomietto","year":"1995","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.neuropharm.2007.03.013_bib24","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0006-3223(89)90042-5","article-title":"Hallucinogenic drugs are partial agonists of the human platelet shape change response: a physiological model of the 5-HT2 receptor","volume":"26","author":"McClue","year":"1989","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2007.03.013_bib25","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1124\/mol.62.6.1339","article-title":"Phospholipase D activation by endogenous 5-hydroxytryptamine 2C receptors is mediated by Galpha13 and pertussis toxin-insensitive Gbetagamma subunits","volume":"62","author":"McGrew","year":"2002","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2007.03.013_bib26","first-page":"390","article-title":"The ratios of serotonin2 and dopamine2 affinities differentiate atypical and typical antipsychotic drugs","volume":"25","author":"Meltzer","year":"1989","journal-title":"Psychopharmacol. Bull."},{"key":"10.1016\/j.neuropharm.2007.03.013_bib27","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1111\/j.1471-4159.1993.tb03595.x","article-title":"Regional distribution and quantitative measurement of the\u00a0phosphoinositidase C-linked guanine nucleotide binding proteins G11 alpha and Gq alpha in rat brain","volume":"61","author":"Milligan","year":"1993","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2007.03.013_bib28","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0166-4328(02)00311-X","article-title":"Anxiolytic-like effects of 5-HT2 ligands on three mouse models of anxiety","volume":"140","author":"Nic Dhonnchadha","year":"2003","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2007.03.013_bib29","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.pharmthera.2003.11.002","article-title":"Hallucinogens","volume":"101","author":"Nichols","year":"2004","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2007.03.013_bib30","doi-asserted-by":"crossref","first-page":"14089","DOI":"10.1073\/pnas.94.25.14089","article-title":"Impaired motor coordination and persistent multiple climbing fiber innervation of cerebellar Purkinje cells in mice lacking Galphaq","volume":"94","author":"Offermanns","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuropharm.2007.03.013_bib31","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1016\/0024-3205(95)02242-9","article-title":"Behavioral effects of (\u00b1)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane, (DOI) in the elevated plus-maze test","volume":"57","author":"Onaivi","year":"1995","journal-title":"Life Sci."},{"key":"10.1016\/j.neuropharm.2007.03.013_bib32","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/1043-6618(94)80096-0","article-title":"Anxiolytic profiles of alprazolam and ethanol in the elevated plus-maze test and the early acquisition of shuttlebox avoidance","volume":"29","author":"Prunell","year":"1994","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.neuropharm.2007.03.013_bib33","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1124\/mol.64.5.1239","article-title":"Selective interaction of ARF1 with the carboxy-terminal tail domain of the 5-HT2A receptor","volume":"64","author":"Robertson","year":"2003","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2007.03.013_bib34","first-page":"924","article-title":"Lysergic acid diethylamide and 2,5-dimethoxy-4-methylamphetamine are partial agonists at serotonin receptors linked to phosphoinositide hydrolysis","volume":"246","author":"Sanders-Bush","year":"1988","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2007.03.013_bib35","first-page":"101","article-title":"1-(2,5-dimethoxy-4 iodophenyl)-2-aminopropane)-induced head-twitches in the rat are mediated by 5-hydroxytryptamine (5-HT) 2A receptors: modulation by novel 5-HT2A\/2C antagonists, D1 antagonists and 5-HT1A agonists","volume":"273","author":"Schreiber","year":"1995","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2007.03.013_bib36","doi-asserted-by":"crossref","first-page":"8846","DOI":"10.1523\/JNEUROSCI.20-23-08846.2000","article-title":"DOI-Induced activation of the cortex: dependence on 5-HT2A heteroceptors on thalamocortical glutamatergic neurons","volume":"20","author":"Scruggs","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2007.03.013_bib37","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00213-002-1252-6","article-title":"Discriminative stimulus properties of 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane [(\u00b1)DOI] in C57BL\/6J mice","volume":"166","author":"Smith","year":"2003","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.neuropharm.2007.03.013_bib38","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0014-2999(96)00233-6","article-title":"Genomic responses to 5-HT1A or 5-HT2A\/2C receptor activation is differentially regulated in four regions of rat brain","volume":"307","author":"Tilakaratne","year":"1996","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2007.03.013_bib39","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0022-3565(24)36840-5","article-title":"Direct injection of 5-HT2A receptor agonists into the medial prefrontal cortex produces a head-twitch response in rats","volume":"282","author":"Willins","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390807000937?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390807000937?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T14:28:35Z","timestamp":1736951315000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390807000937"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6]]},"references-count":39,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2007,6]]}},"alternative-id":["S0028390807000937"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2007.03.013","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2007,6]]}}}